Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Gun Ei Chemical Industry Co., Ltd. (4229:JPX), powered by AI.
Gun Ei Chemical Industry Co., Ltd. is currently trading at ¥4,945. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Gun Ei Chemical Industry Co., Ltd. on Alpha Lenz.
Gun Ei Chemical Industry Co., Ltd.'s P/E ratio is 17.1.
“Gun Ei Chemical Industry Co., Ltd. trades at a P/E of 17.1 (fair value) with modest ROE of 3.9%.”
Ask for details →Gun Ei Chemical Industry Co., Ltd. is a specialized entity in pharmaceutical and chemical manufacturing. The company's core function involves the development and production of active pharmaceutical ingredients (APIs), which serve as essential components in the formulation of various medical drugs. Gun Ei Chemical Industry Co., Ltd. plays a significant role in the healthcare sector, providing key materials that ensure the efficacy and safety of pharmaceuticals employed in diverse treatments. Aside from pharmaceuticals, Gun Ei Chemical Industry engages in the chemical sector, offering products and solutions that support industries such as agriculture, cosmetics, and specialty chemicals. These sectors rely on high-quality chemical compounds and innovative solutions to enhance product formulations and production processes. Headquartered in Japan, Gun Ei Chemical Industry Co., Ltd. contributes significantly to the global supply chain of medical and industrial chemicals. The company's expertise in chemical engineering and dedication to quality assurance positions it as a vital player in sectors that value precision and reliability, making it a pivotal contributor to the broader financial market and healthcare industries.
“Gun Ei Chemical Industry Co., Ltd. trades at a P/E of 17.1 (fair value) with modest ROE of 3.9%.”
Ask for details →Gun Ei Chemical Industry Co., Ltd. (ticker: 4229) is a company listed on JPX in the Basic Materials sector (Specialty Chemicals). It has approximately 537 employees. Market cap is $32.8B.
The current price is 4,945 with a P/E ratio of 17.07x and P/B of 0.66x.
ROE is 3.91% and operating margin is 7.51%. Annual revenue is $30.5B.